News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Opinion|Videos|May 29, 2024

Role of Pharmacists in Operationalizing Bispecific Antibodies

Author(s)Ryan Haumschild, PharmD, MS, MBA, Ke Ning, MD, Sarah Rockwell, PharmD, BCOP

Medical professionals highlight the essential support provided by pharmacists in addressing operational challenges related to bispecific antibodies. Pharmacists can play an important role in the development of policies and procedures, monitoring and management of toxicities, and delivery of educational resources.

Episodes in this series

Video 1 - "Impact of Bispecific Antibodies on Multiple Myeloma Treatment"

EP. 1 Impact of Bispecific Antibodies on Multiple Myeloma Treatment

Video 2 - "Key Considerations in Treatment Selection for Patients With Multiple Myeloma"

EP. 2 Key Considerations in Treatment Selection for Patients With Multiple Myeloma

Video 3 - "Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody"

EP. 3 Monitoring and Treating Adverse Events in Patients Receiving Treatment With a Bispecific Antibody

Video 4 - "Risk Evaluation Mitigation Strategy (REMS) Program Requirements for Bispecific Antibodies"

EP. 4 Risk Evaluation Mitigation Strategy (REMS) Program Requirements for Bispecific Antibodies

Video 5 - "The Importance of Engaging Stakeholders When Implementing Bispecific Antibodies"

EP. 5 The Importance of Engaging Stakeholders When Implementing Bispecific Antibodies

Video 6 - "Stakeholder Perspective: Step-Up Dosing for Bispecific Antibodies in Multiple Myeloma"

EP. 6 Stakeholder Perspective: Step-Up Dosing for Bispecific Antibodies in Multiple Myeloma

Video 7 - "Overcoming Challenges Related to Bispecific Antibody Adoption in Multiple Myeloma"

EP. 7 Overcoming Challenges Related to Bispecific Antibody Adoption in Multiple Myeloma

Video 8 - "Final Thoughts on Operationalization of Bispecific Antibodies for Multiple Myeloma"

EP. 8 Final Thoughts on Operationalization of Bispecific Antibodies for Multiple Myeloma

Video 09 - "Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma"

EP. 9 Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma

Video 09 - "Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma"

EP. 10 Multidisciplinary Team Approach to Adverse Effect Monitoring for Bispecifics in MM

Video 11 - "Complying with REMS Training and Documentation Requirements"

EP. 11 Complying with REMS Training and Documentation Requirements

Video 12 - "Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM"

EP. 12 Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM

Video 12 - "Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM"

EP. 13 Unmet Needs in Multiple Myeloma Care

Video 12 - "Pharmacist Role in Addressing Operational Challenges of Bispecifics in MM"

EP. 14 Treatment Sequencing and Combination Therapies for MM

Video 15 - "Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM "

EP. 15 Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM

Video 1 - "Impact of the Introduction of Bispecifics on the Management of Multiple Myeloma"

EP. 16 Impact of the Introduction of Bispecifics on the Management of Multiple Myeloma

Video 2 - "Key Results From the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 Trials"

EP. 17 Key Results From the MajesTEC-1, MonumenTAL-1, and MagnetisMM-3 Trials

A panel of 3 experts on multiple myeloma

EP. 18 Identifying Patients Who Are Candidates for Bispecifics and Referring Patients for Care

A panel of 3 experts on multiple myeloma

EP. 19 Collaborating with Other Care Providers to Optimize Outcomes for Patients Receiving Bispecifics

A panel of 3 experts on multiple myeloma

EP. 20 Considerations for Maintenance Therapy in the Community Oncology Setting

A panel of 3 experts on multiple myeloma

EP. 21 Team Approach to Meeting REMS Program Requirements

Video 7 - "Role of Pharmacists in Operationalizing Bispecific Antibodies"

EP. 22 Role of Pharmacists in Operationalizing Bispecific Antibodies

Video 8 - "Bispecific Antibodies Versus CAR T-Cell Therapy for RRMM in the Community Oncology Setting"

EP. 23 Bispecific Antibodies Versus CAR T-Cell Therapy for RRMM in the Community Oncology Setting

$Video 9 - "Unmet Needs in Relapsed or Refractory Multiple Myeloma"$

EP. 24 Unmet Needs in Relapsed or Refractory Multiple Myeloma

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Content

Image credit: Chinnapong | stock.adobe.com

Q&A: First-in-Class NSD2 Inhibitor KTX-1001 Shows Promise in High-Risk Multiple Myeloma

BySaad Z. Usmani, MD, MBA, FACP, FASCO,Kennedy Ferruggia, Associate Editor

February 4th 2026

Multiple Myeloma is a cancer of plasma cells, a type of white blood cell found in bone marrow - Image credit: kamonrat | stock.adobe.com

Expert: Early Phase 1 Data Show KTX-1001 Targeting NSD2 Offers Promise for Relapsed/Refractory Multiple Myeloma

BySaad Z. Usmani, MD, MBA, FACP, FASCO,Kennedy Ferruggia, Associate Editor

February 3rd 2026

'FDA APPROVED' stamped on textured paper, beside a magnifying glass and wooden rubber stamp, symbolizing certification, quality assurance, and regulatory approval | Image Credit: StocksJust4You | adobe.stock.com

FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma

ByDanielle Valletti, Assistant Editor

January 27th 2026

MULTIPLE MYELOMA - words on wooden red bars on a blue background with pills | Image Credit: Zhanna | stock.adobe.com

FDA Draft Guidance Signals Shift Toward MRD, Complete Response as Accelerated Approval End Points in Multiple Myeloma

ByDanielle Valletti, Assistant Editor

January 26th 2026

Flame-shaped plasma cells associated with multiple myeloma, focusing on disease awareness | Image Credit: The 2R Artificiality | stock.adobe.com

Early-Line Immunotherapy Challenges the Role of Transplant in Multiple Myeloma

ByDanielle Valletti, Assistant Editor

January 23rd 2026

Latest CME

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Pharmacy Technician Credit)

0.5 Credit / Immunization

Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the Spread of HIV

On-Demand Virtual Symposium

Exploring HIV Long-Acting Injectable Uptake: How Pharmacists Can Encourage Long-Acting Injectables to Stem the Spread of HIV

1.5 Credits / HIV/AIDS, Infectious Disease

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

On-Demand Webinar

Optimizing LDL-C Lowering and Adherence to Hyperlipidemia Guidelines

1.0 Credit / Cardiology

The Role of the Pharmacist in the Management of Hyperlipidemia

On-Demand Webinar

The Role of the Pharmacist in the Management of Hyperlipidemia

1.0 Credit / Cardiology

APhA 2026

In-Person + Virtual Event

APhA 2026

March 28-29, 2026

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs (Pharmacy Technician Credit)

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs (Pharmacy Technician Credit)

2.0 Credits / General Pharmacy

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

On-Demand Webinar

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

1.0 Credit / Pulmonology/Respiratory

Understanding the Pearls and Pitfalls of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Opportunities to Improve Patient Outcomes

Webinar Registration

Understanding the Pearls and Pitfalls of Nimodipine in Aneurysmal Subarachnoid Hemorrhage: Opportunities to Improve Patient Outcomes

February 19, 2026 | March 5, 2026 | 1:00 PM & 8:00 PM ET

2025 SABCS Abstracts to Action: From Data to Decisions in HR+ Breast Cancer Care

Panel Discussion Registration

2025 SABCS Abstracts to Action: From Data to Decisions in HR+ Breast Cancer Care

February 23, 2026 | 7:00 PM ET

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

0.5 Credit / Immunology

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Part 2)

0.5 Credit / Immunization

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technician Credit)

Case Conversation

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion (Pharmacy Technician Credit)

0.75 Credit / Immunization

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

Case Conversation

Implementing Updated RSV Vaccination Recommendations for Older Adults: RSV Case Discussion

0.75 Credit / Immunization

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Incorporating ACIP Guidelines (Pharmacy Technician Credit)

0.5 Credit / Immunization

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

0.5 Credit / Immunization

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

Best Practices for Management of Hyperlipidemia: A Focus on Guidelines and Patient Adherence

0.5 Credit / Cardiology

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

On-Demand Webinar

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Part 3)

0.5 Credit / Immunization

Advancing AML Care: Equipping Pharmacists to Implement Menin Inhibitor Therapies with Precision

Webinar Registration

Advancing AML Care: Equipping Pharmacists to Implement Menin Inhibitor Therapies with Precision

Thursday, March 5, 2026 | 12:00 PM & 7:00 PM ET

Navigating Diabetes: A Guide to Effective Oral Treatments

Navigating Diabetes: A Guide to Effective Oral Treatments

1.0 Credits / Endocrinology, Diabetes & Metabolism

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

On-Demand Virtual Symposium

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

1.5 Credits / Pain Management/Opioids

Hyperlipidemia Overview and the Clinical and Economic Burden

On-Demand Webinar

Hyperlipidemia Overview and the Clinical and Economic Burden

1.0 Credit / Cardiology

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on Pharmacy Times

TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs

Enlicitide Meaningfully Lowers LDL-C at 24 Weeks in Patients At Risk for ASCVD Events

SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury

Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment

Balancing Survival and Quality of Life in Pancreatic Cancer: Expert Perspectives From an Immuneering Panel